Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local antibacterial efficacy of octenidine wound gel on pre-damaged skin
2010-024572-25Phase 2Completed
- Sponsor
- Dr. August Wolff
- Start
- Jan 2011
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of octenidine in skin and soft tissue infections (SSTIs) (3 arms), sponsored by Dr. August Wolff. Primary endpoint: Primary antibacterial efficacy. Started Jan 2011; status: completed.
02
Drugs
octenidine
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on 2010-024572-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024572-25.